Avalo Therapeutics, Inc. ($AVTX)
Doyle Mittie โ Chief Medical Officer
Shares
19,500
Price
$12.65
Total Value
$246,675.00
Nearby Earnings
Mar 19, 2026
EPS:Est: -1.46
Transaction Details
| Insider | Doyle Mittie |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Mar 16, 2026 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 18, 2026 |
| Shares Purchased | 19,500 |
| Price per Share | $12.65 |
| Total Value | $246,675.00 |
| Shares Owned After | 23,122 |
| Derivative | No |
| Accession Number | 0001918845-26-000004 |
| Document | View SEC Filing |